UAE-based camel milk company, Camelicious, which has more than 40 camel milk products in its range, is looking to change that.
DairyReporter spoke with the company’s regional sales manager, Europe, Martin Lilley, at the SIAL food show in Paris recently, as the company looked to increase its presence in the European markets.
Camel milk has been widely studied for its anti-inflammatory properties, and only recently a study into camel whey investigated its potential in anti-cancer trials.
Other recent studies suggest camel milk has a positive effect on Type 2 diabetes patients. Studies in India show regular consumption of camel milk helps reduce the required amount of insulin injections. Other research currently in progress is looking into the positive effects of camel milk on patients with hepatitis, autoimmune diseases, Crohn’s disease, autism and rheumatism.
Camel milk is low in fat; the fat content is approximately 50% lower than cow’s milk. It contains a high percentage of unsaturated fatty acids, and is rich in natural vitamin C. The content of this immune boosting vitamin is three to five times higher than in cow’s milk. There are no known allergies to camel milk.
Camelicious has introduced a host of camel products into the market, the most recent being an infant formula launched in the Middle East.
As milk yield per animal is lower, product prices are generally higher, however, Camelicious is able to take advantage of its large herd of 7,000 camels to continue to innovate, which also includes branching out into cosmetics.
Camelicious looks to European market